OCM
PFE icon

Orrell Capital Management’s Pfizer PFE Stock Holding History

Orrell Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,054
Closed -$31K – 30
2014
Q4 		$31K Hold
1,054
– – 0.05% 28
2014
Q3 		$29K Buy
+1,054
New +$29.6K 0.04% 35

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Orrell Capital Management's PFE Position: Q1 2015 in Review

Orrell Capital Management sold out of Pfizer (PFE) in Q1 2015, closing a stake of 1,054 shares — an estimated $31K sold.

Orrell Capital Management first reported a position in PFE in Q3 2014 and held it in 2 quarters. The position peaked at $31K in Q4 2014. 1,876 funds tracked by Wall St. Rank hold PFE as of Q1 2015.

  • Orrell Capital Management reported no remaining Pfizer position as of Q1 2015 after selling out during the quarter.
  • Orrell Capital Management sold 1,054 Pfizer shares in Q1 2015, an estimated $31K.
  • Orrell Capital Management first reported a position in Pfizer in Q3 2014 and held it in 2 quarters.
  • Orrell Capital Management's Pfizer position peaked at $31K in Q4 2014.
  • 1,876 funds tracked by Wall St. Rank held Pfizer as of Q1 2015.

Based on Orrell Capital Management's 13F filing for Q1 2015, filed 6 May 2015.